Home/ Supplements/ Vitamin K/ Vitamin K2

Vitamin K2

product on market Softgel Capsule AOR Advanced Orthomolecular Research Premium Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is researched for its role in supporting bone health and calcium metabolism by regulating proteins that bind calcium to the bone matrix. There is moderate to strong evidence suggesting it helps prevent arterial calcification. The ingredient profile maintains a high safety rating for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

120 mcg (100% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)

Other Ingredients

organic Coconut Oil Microcrystalline Cellulose Softgel Sunflower Vitamin E Tocopherols
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 1 softgel per day with or without food, or as directed by a qualified health care practitioner.

Warnings & Precautions

Do not use if safety seal is broken

Warning: Consult your physician before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication (blood thinners).

Keep out of reach of children.

Contains: tree nuts (coconuts).

To report a serious adverse event or obtain product information, call 1-866-215-0450

Formulation Notes

GMP Manufacturing Quality assured Independent testing

Discussion: Vitamin K2 from AOR provides MK-4 and MK-7, the two optimal forms of Vitamin K2. Formulated using AOR’s patent pending VSoftgel technology for superior absorption.

Active MK-4 and M-7

Carrageenan free

Vegan

Non-GMO Gluten free

Absorbable Eco

AOR guarantees that all ingredients have been declared on the label.

Made without wheat, gluten, corn, peanuts, sesame seeds, mustard, dairy, sulfites, eggs, soy, fish, shellfish or any animal byproduct.

Additional Information

Store tightly sealed in a cool, dry place

Product of Canada

Metadata

Product Details

UPC / SKU6 24917 08376 7
DSLD Entry Date2020-03-24
Product TypeVitamin
FormSoftgel Capsule
DSLD ID214735
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.